Literature DB >> 21234643

Morphine facilitates doxorubicin penetration in the central nervous system: a new prospect for therapy of brain tumors.

Iacopo Sardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21234643     DOI： 10.1007/s11060-010-0518-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  13 in total

1.  Quantification of early blood-brain barrier disruption by in situ brain perfusion technique.

Authors:  A K Bhattacharjee; T Nagashima; T Kondoh; N Tamaki
Journal:  Brain Res Brain Res Protoc       Date:  2001-10

2.  Alterations in blood-brain barrier function by morphine and methamphetamine.

Authors:  Hari Shanker Sharma; Syed F Ali
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

3.  Using blood brain barrier disruption by methamphetamine for drug delivery.

Authors:  R E Kast
Journal:  J Neurooncol       Date:  2007-04-27       Impact factor: 4.130

4.  Intratumoral doxorubicin in patients with malignant brain gliomas.

Authors:  Spyridoy Voulgaris; Melpomeni Partheni; Michalis Karamouzis; Panayiotis Dimopoulos; Nicolaos Papadakis; Haralabos P Kalofonos
Journal:  Am J Clin Oncol       Date:  2002-02       Impact factor: 2.339

5.  Detection of doxorubicin hydrochloride accumulation in the rat brain after morphine treatment by mass spectrometry.

Authors:  Iacopo Sardi; Giancarlo la Marca; Maria Grazia Giovannini; Sabrina Malvagia; Renzo Guerrini; Lorenzo Genitori; Maura Massimino; Maurizio Aricò
Journal:  Cancer Chemother Pharmacol       Date:  2010-08-25       Impact factor: 3.333

6.  Local delivery of doxorubicin for the treatment of malignant brain tumors in rats.

Authors:  Maciej S Lesniak; Urvashi Upadhyay; Rory Goodwin; Betty Tyler; Henry Brem
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

7.  Effect of chronic exposure to morphine on the rat blood-brain barrier: focus on the P-glycoprotein.

Authors:  Salah Yousif; Bruno Saubaméa; Salvatore Cisternino; Cynthia Marie-Claire; Sandrine Dauchy; Jean-Michel Scherrmann; Xavier Declèves
Journal:  J Neurochem       Date:  2008-08-30       Impact factor: 5.372

8.  Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles.

Authors:  Sebastian C J Steiniger; Jörg Kreuter; Alexander S Khalansky; Igor N Skidan; Alexey I Bobruskin; Zoya S Smirnova; Sergey E Severin; Reiner Uhl; Martin Kock; Kathrin D Geiger; Svetlana E Gelperina
Journal:  Int J Cancer       Date:  2004-05-01       Impact factor: 7.396

9.  Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.

Authors:  Peter Hau; Klaus Fabel; Ulrike Baumgart; Petra Rümmele; Oliver Grauer; Annekatrin Bock; Christopher Dietmaier; Wolfgang Dietmaier; Jörg Dietrich; Christine Dudel; Franz Hübner; Tanya Jauch; Elisabeth Drechsel; Ingo Kleiter; Cäcile Wismeth; Anton Zellner; Alexander Brawanski; Andreas Steinbrecher; Jörg Marienhagen; Ulrich Bogdahn
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

10.  Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.

Authors:  T Inamura; K L Black
Journal:  J Cereb Blood Flow Metab       Date:  1994-09       Impact factor: 6.200
View more
  6 in total

1.  Morphine modulates doxorubicin uptake and improves efficacy of chemotherapy in an intracranial xenograft model of human glioblastoma.

Authors:  Martina da Ros; Anna Lisa Iorio; Dario Consolante; Francesco Cardile; Monica Muratori; Ornella Fantappiè; Maurizio Lucchesi; Milena Guidi; Claudio Pisano; Iacopo Sardi
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

2.  Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain.

Authors:  Iacopo Sardi; Giancarlo la Marca; Stefania Cardellicchio; Laura Giunti; Sabrina Malvagia; Lorenzo Genitori; Maura Massimino; Maurizio de Martino; Maria G Giovannini
Journal:  Am J Cancer Res       Date:  2013-08-14       Impact factor: 6.166

Review 3.  The blood-brain barrier and methamphetamine: open sesame?

Authors:  Patric Turowski; Bridget-Ann Kenny
Journal:  Front Neurosci       Date:  2015-05-05       Impact factor: 4.677

Review 4.  The Use of Anthracyclines for Therapy of CNS Tumors.

Authors:  Martina da Ros; Anna Lisa Iorio; Maurizio Lucchesi; Alessia Stival; Maurizio de Martino; Iacopo Sardi
Journal:  Anticancer Agents Med Chem       Date:  2015       Impact factor: 2.505

5.  Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma.

Authors:  Anna Lisa Iorio; Martina da Ros; Lorenzo Genitori; Maurizio Lucchesi; Fabiana Colelli; Giacomo Signorino; Francesco Cardile; Giacomo Laffi; Maurizio de Martino; Claudio Pisano; Iacopo Sardi
Journal:  Oncotarget       Date:  2017-08-03

Review 6.  Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases.

Authors:  Anna Lisa Iorio; Martina da Ros; Ornella Fantappiè; Maurizio Lucchesi; Ludovica Facchini; Alessia Stival; Sabrina Becciani; Milena Guidi; Claudio Favre; Maurizio de Martino; Lorenzo Genitori; Iacopo Sardi
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.